Analyst Ratings for Transcept Pharmaceuticals (TSPT)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/1/2011 | McNicoll Lewis & Vlak | N/A | Upgrade | Buy (N/A) |
21.00 (N/A) |
8.72 (7.20) |
-17.43% | Details |
| 10/5/2011 | Lazard Capital | N/A | Upgrade | Buy (N/A) |
22.00 (N/A) |
8.08 (7.20) |
-10.89% | Details |
